These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 17408406)
1. The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials. Lazo-Langner A; Goss GD; Spaans JN; Rodger MA J Thromb Haemost; 2007 Apr; 5(4):729-37. PubMed ID: 17408406 [TBL] [Abstract][Full Text] [Related]
2. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials. Sanford D; Naidu A; Alizadeh N; Lazo-Langner A J Thromb Haemost; 2014 Jul; 12(7):1076-85. PubMed ID: 24796727 [TBL] [Abstract][Full Text] [Related]
3. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis. Chande N; McDonald JW; Macdonald JK Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969 [TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children. Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulation for people with cancer and central venous catheters. Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471 [TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation. Lin PT; Wang SH; Chi CC Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657 [TBL] [Abstract][Full Text] [Related]
8. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837 [TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. Iorio A; Guercini F; Pini M J Thromb Haemost; 2003 Sep; 1(9):1906-13. PubMed ID: 12941030 [TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation. Chen YC; Chi CC; Chan FC; Wen YW Cochrane Database Syst Rev; 2013 Jul; (7):CD009894. PubMed ID: 23836382 [TBL] [Abstract][Full Text] [Related]
12. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis. Chande N; McDonald JW; Macdonald JK; Wang JJ Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749 [TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparin and cancer survival: review of the literature and pooled analysis of 1,726 patients treated for at least three months. Conti S; Guercini F; Iorio A Pathophysiol Haemost Thromb; 2003 Jul-2004 Aug; 33(4):197-201. PubMed ID: 15583449 [TBL] [Abstract][Full Text] [Related]
14. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Potdar N; Gelbaya TA; Konje JC; Nardo LG Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476 [TBL] [Abstract][Full Text] [Related]
16. A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications. Kuderer NM; Khorana AA; Lyman GH; Francis CW Cancer; 2007 Sep; 110(5):1149-61. PubMed ID: 17634948 [TBL] [Abstract][Full Text] [Related]
17. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Di Nisio M; Porreca E; Otten HM; Rutjes AW Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736 [TBL] [Abstract][Full Text] [Related]
18. The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients: A Systematic Review and Meta-Analysis. Montroy J; Lalu MM; Auer RC; Grigor E; Mazzarello S; Carrier M; Kimmelman J; Fergusson DA Thromb Haemost; 2020 May; 120(5):832-846. PubMed ID: 32369854 [TBL] [Abstract][Full Text] [Related]
19. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801 [TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]